Business Wire

HighLife Appoints Dr. Martin Rothman as Independent Member of the Board

Jaa

HighLife SAS, a medtech company focused on the development of a unique trans-catheter mitral valve replacement (TMVR) system to treat patients suffering from mitral regurgitation, announced today the appointment of Dr. Martin T. Rothman as non-executive independent member of its Board of Directors.

Dr. Rothman retired recently from his position as Vice President of medical affairs for coronary, structural heart and renal denervation, for Medtronic, based in Santa Rosa (CA), a position he held since 2010. He was involved in the development of the renal denervation program, TAVR, and the Medtronic percutaneous mitral regurgitation program, including Twelve and development of its Intrepid TMVR product and associated clinical strategy.

Dr. Rothman trained as an interventional cardiologist in Bart Hospital Trust, UK. Then, as a world-renowned interventional cardiologist, he worked for the UK National Health Service for almost 40 years. He has been a leading investigator in research involving drug-eluting coronary stents and cardiac stem-cell treatment, and helped develop intravascular ultrasound technology. Dr. Rothman also currently holds several positions in start-up companies in the cardiovascular field, some as a founder and based on his own inventions.

“I am excited to join the HighLife team and a very experienced board and to contribute to the establishment of its unique percutaneously delivered mitral valve prosthesis which is self-locating and if necessary removable. This will be a major opportunity for a large number of patients,” said Dr. Rothman.

Based in Paris (France), HighLife was started in 2010 by Georg Börtlein, CEO and member of the Board. Following the recent investment in HighLife from Sofinnova Partners, Antoine Papiernik joined the company’s Board. Mano Iyer, founder and COO of the medtech start-up ReCor Medical, continues to serve as an independent member. In December 2017, Jose (Pepe) Calle Gordo, most recently CEO of Biosensors and with a long successful career in cardiovascular devices, was named Chairman.

“We are honored to have Martin Rothman join the company’s Board of Directors. It is a clear validation of the significant progress made with this technology as well as its future potential to address the unmet needs of patients with mitral regurgitation. His extensive medical background and unique track record in the interventional cardiology field will add tremendous value to our team and in combination with the rest of the Board of Directors, is creating a strong foundation which will lead to clinical and regulatory success,” said Mr Calle Gordo.

“I am delighted we could attract a Director with the talent and experience of Dr. Rothman. We will greatly benefit from his experience and strategic vision of structural heart along with his ability to build clinical strategies,” said Georg Börtlein.

The HighLife technology is best-in-class as it can be delivered transseptally via the femoral vein in a reversible manner, and as it self-locates inside the native annulus. The transseptal route is the preferred route for both interventionists and patients as it avoids any surgery.

Contact information

STRATEGIES & IMAGE
Anne Rein, +33-6-0335-9205
anne.rein@strategiesimage.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Axonics® Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares19.11.2018 19:30Tiedote

Axonics Modulation Technologies, Inc. (NASDAQ: AXNX) (“Axonics”), a medical technology company focused on the design, development and commercialization of innovative and minimally invasive sacral neuromodulation (“SNM”) solutions for the treatment of overactive bladder (“OAB”), fecal incontinence (“FI”), and urinary retention (“UR”), today announced that the underwriters of its initial public offering exercised in full their option to purchase an additional 1,200,000 shares of common stock from Axonics at the initial public offering price of $15.00 per share, less underwriting discounts and commissions. With this exercise, the total number of shares of common stock sold by Axonics in the offering increased to 9,200,000 shares, representing total gross proceeds of $138 million, before underwriting discounts and commissions and offering expenses. Axonics’ common stock began trading on The Nasdaq Global Select Market under the ticker symbol “AXNX” on October 31, 2018. BofA Merrill Lynch a

Jefferies Appoints Fred Jallot Head of Fixed Income in Europe19.11.2018 17:52Tiedote

Jefferies today announced the appointment of Fred Jallot as Head of Fixed Income, Europe. He will be based in the firm’s London office starting January 2, 2019 and will report to Fred Orlan, Global Head of Fixed Income at Jefferies. Tim Cronin, who has also served as Head of Fixed Income, Europe, will relinquish this role and continue to serve as President of Jefferies International Limited, Jefferies’ London-based subsidiary. “We are very excited to have Fred Jallot join Jefferies’ leading global fixed income platform,” commented Mr. Orlan. “As a broadly experienced professional in global fixed income, his relationships and leadership will further enhance Jefferies’ growth in this market. This senior hire is an example of Jefferies’ emphasis on enhancing our firm’s European capabilities to serve our regional and global client base,” he added. Mr. Jallot was most recently Global Head of Credit and Asset-Backed Securities in Europe, the Middle East and Africa at Nomura, and previously s

From Niche to Normal – Cannabis Use Becoming More Accepted in the United States19.11.2018 17:47Tiedote

Growing numbers of consumers support the legalization of cannabis in some form and a majority believes it has a positive impact on the economy, according to the newly released 2018 Fall Cannabis Culture Poll, developed jointly by leading global communications agency BCW (Burson Cohn & Wolfe), PSB Research and Civilized, a premium media and lifestyle brand that embraces and highlights modern cannabis culture. A full 83 percent of the poll’s respondents (U.S. adults, cannabis consumers and non-consumers) say they support some form of legalization of cannabis. Sixty-three percent of non-consumers, and 95 percent of cannabis consumers, say legalization has had a positive economic effect on the states where use has been made legal. PSB Research, in partnership with BCW and Civilized, conducted online interviews between September 26 and October 4, 2018 with 1,200 U.S. adults aged 21 and older to explore views on cannabis and its usage and to determine general habits and behaviors of those wh

FRISS: Insurance Carriers Prioritize Fraud Detection and Prevention19.11.2018 16:00Tiedote

Insurance fraud is a global problem. In the U.S. alone, insurance carriers lost over $34 billion in 2017 on fraudulent insurance claims. It’s a global problem with a growing number of technological solutions. Big data analysis and large-scale collaboration are key to fighting insurance fraud. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181119005015/en/ Insurance Fraud Report by FRISS (Graphic: Business Wire) The insurance industry is increasingly focused on preventing fraud through innovative systems, relying on the assistance of specialized vendors to help accomplish the task. The burden of detecting and reducing fraud, therefore, no longer lies with the individual insurer. The 2018 FRISS Insurance Fraud Survey reached over 150 industry professionals and shows a clear picture of the current awareness and challenges of fraud detection and mitigation. Key survey findings show: Increased focus on data quality The quality of

BOC Group´s ADOIT Receives the Highest Score in “Rearchitecting the Enterprise for Transformation” Use Case in Gartner’s 2018 Critical Capabilities for Enterprise Architecture Tools19.11.2018 15:04Tiedote

BOC Group, the leading global provider of Enterprise Management Solutions, is pleased to share its recognition in Gartner’s latest Critical Capabilities Report for Enterprise Architecture Tools*. ADOIT scores within the two highest across all three use cases, while scoring the highest out of eleven tools in “Rearchitecting the Enterprise for Transformation” use case. Christoph Moser, ADOIT product manager comments: "It is satisfying to be recognized by Gartner for our capabilities, which we are certain is due to our unique value proposition and holistic offering. We believe that our scores in this year's Gartner Critical Capabilities for Enterprise Architecture Tools report demonstrate our strength, innovation and continued investment in the agility, flexibility and versatility of our EA portfolio”. The Business Transformation Suite ADOIT supports customers worldwide in the digital transformation of their enterprise, facilitates alignment of their business and IT, and helps generate va

Chubu Centrair International Airport Has Been Ranked 5-Star Airport for Second Time19.11.2018 14:19Tiedote

Chubu Centrair International Airport has been ranked for the second consecutive year as a 5-star Airport*1, the world highest airport rank, in the Regional Airport*2 category. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181119005317/en/ In order to reply to the diversifying needs of the increasing international travellers, Chubu Centrair International Airport is aiming to become an easier to use and a more comfortable airport. In SKYTRAX’s*3 survey, which includes over 500 airport evaluation categories, Chubu Centrair International Airport has ranked specially high in “Airport staff service” and ”Airport cleanness” among other airports. In addition, Chubu Centrair International Airport has been also awarded in SKYTRAX’s “World Airport Awards”, an international airport rating based on client service, as “The World’s Best Regional Airport” (for 4th consecutive year since 2015) and ”Best Regional Airport-Asia” (for 8th conse

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme